Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-30.87%
operating margin TTM
-33.35%
revenue TTM
903.79 Million
revenue per share TTM
5.47$
valuation ratios | |
|---|---|
| pe ratio | -38.21 |
| peg ratio | 7.13 |
| price to book ratio | 25.40 |
| price to sales ratio | 11.83 |
| enterprise value multiple | 2.35 |
| price fair value | 25.40 |
profitability ratios | |
|---|---|
| gross profit margin | 98.35% |
| operating profit margin | -33.35% |
| pretax profit margin | -30.74% |
| net profit margin | -30.87% |
| return on assets | -9.47% |
| return on equity | -58.57% |
| return on capital employed | -12.91% |
liquidity ratios | |
|---|---|
| current ratio | 4.10 |
| quick ratio | 4.09 |
| cash ratio | 0.24 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 116.09 |
| operating cycle | 141.51 |
| days of payables outstanding | 543.78 |
| cash conversion cycle | -402.27 |
| receivables turnover | 14.36 |
| payables turnover | 0.67 |
| inventory turnover | 3.14 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.59 |
| debt equity ratio | 4.15 |
| long term debt to capitalization | 0.73 |
| total debt to capitalization | 0.81 |
| interest coverage | -4.41 |
| cash flow to debt ratio | -0.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.89 |
| cash per share | 11.64 |
| operating cash flow per share | -5.52 |
| free cash flow operating cash flow ratio | 1.07 |
| cash flow coverage ratios | -0.45 |
| short term coverage ratios | -2.11 |
| capital expenditure coverage ratio | -15.02 |
Frequently Asked Questions
When was the last time Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) reported earnings?
Ionis Pharmaceuticals, Inc. (IONS) published its most recent earnings results on 29-04-2026.
What is Ionis Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)'s trailing twelve months ROE is -58.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ionis Pharmaceuticals, Inc. (IONS) currently has a ROA of -9.47%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IONS's net profit margin stand at?
IONS reported a profit margin of -30.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IONS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.10 in the most recent quarter. The quick ratio stood at 4.09, with a Debt/Eq ratio of 4.15.